Home Here's what Dr. John Niederhuber says is critical to unlocking...
 

Keywords :   


Here's what Dr. John Niederhuber says is critical to unlocking...

2015-04-09 22:11:57| Chemicals - Topix.net

Dr. John Niederhuber, CEO of the Inova Translational Medicine Institute, spoke with the Washington Business Journal April 9 at the Northern Virginia Technology Council's Titans Breakfast Series event in McLean. Dr. John Niederhuber, CEO of Inova Health's Translational Medicine Institute, left, and Inova Health CEO Knox Singleton shown in February as they announced the acquisition of the Exxon Mobil campus across the street from Inova's Fairfax Hospital to advanced cancer and personalized medicine research.

Tags: to john critical unlocking

Category:Chemicals

Latest from this category

All news

26.06Automotive Color by BASF Recognized with Renowned Red Dot Award
26.06Beckers Commits to Widespread Science Based Targets
26.06PPG to Announce Second-quarter 2024 Results July 18
26.06Fresh Coat for First Responders: New Hampshire Fire Station Gets a Makeover by California Paints
26.06WEG Mexico Obtains Quality Certificate from QUALICOAT
26.06Cool Roof Coatings Market to Reach US$9.2B by 2030: Fairfield
25.06Briolf Group to Invest $30 Million in Its First US Production Plant
25.06Sherwin-Williams Announces 2023 Water and Wastewater Impact Award Winners
Chemicals »
26.06Atlantic Tropical Weather Outlook
26.06Eastern North Pacific Tropical Weather Outlook
26.06XREAL bring Play Store apps to 3D space on XREAL AR glasses
26.06Qwilt reveals live streaming survey results
26.06Rockline Industries Wins WOW Innovation Award
26.06IMS Technologies Expands Calcinate Production Site
26.06Horizon expert 'gave evidence based on informal chats'
26.06Automotive Color by BASF Recognized with Renowned Red Dot Award
More »